[go: up one dir, main page]

PT852497E - Utilizacao de derivados de prostano e a sua combinacao com antibioticos no tratamento de infeccoes bacterianas - Google Patents

Utilizacao de derivados de prostano e a sua combinacao com antibioticos no tratamento de infeccoes bacterianas

Info

Publication number
PT852497E
PT852497E PT96929216T PT96929216T PT852497E PT 852497 E PT852497 E PT 852497E PT 96929216 T PT96929216 T PT 96929216T PT 96929216 T PT96929216 T PT 96929216T PT 852497 E PT852497 E PT 852497E
Authority
PT
Portugal
Prior art keywords
combination
pct
antibiotics
utilization
treatment
Prior art date
Application number
PT96929216T
Other languages
English (en)
Inventor
Peter Scholz
Jorg Weber
Klemens Angstwurm
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of PT852497E publication Critical patent/PT852497E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/558—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes
    • A61K31/5585—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes having five-membered rings containing oxygen as the only ring hetero atom, e.g. prostacyclin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT96929216T 1995-08-11 1996-08-06 Utilizacao de derivados de prostano e a sua combinacao com antibioticos no tratamento de infeccoes bacterianas PT852497E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19530884A DE19530884C2 (de) 1995-08-11 1995-08-11 Verwendung von Prostan-Derivaten sowie deren Kombination mit Antibiotika zur Behandlung von bakteriellen Meningitis

Publications (1)

Publication Number Publication Date
PT852497E true PT852497E (pt) 2002-10-31

Family

ID=7770106

Family Applications (1)

Application Number Title Priority Date Filing Date
PT96929216T PT852497E (pt) 1995-08-11 1996-08-06 Utilizacao de derivados de prostano e a sua combinacao com antibioticos no tratamento de infeccoes bacterianas

Country Status (25)

Country Link
US (1) US6040336A (pt)
EP (1) EP0852497B1 (pt)
JP (1) JPH11510809A (pt)
CN (1) CN1080562C (pt)
AT (1) ATE219368T1 (pt)
AU (1) AU702706B2 (pt)
BR (1) BR9609932A (pt)
CA (1) CA2228036A1 (pt)
CZ (1) CZ291534B6 (pt)
DE (2) DE19530884C2 (pt)
DK (1) DK0852497T3 (pt)
ES (1) ES2181907T3 (pt)
HK (1) HK1015707A1 (pt)
HU (1) HUP9802450A3 (pt)
IL (1) IL122826A (pt)
MX (1) MX9801118A (pt)
NO (1) NO316424B1 (pt)
PL (1) PL184840B1 (pt)
PT (1) PT852497E (pt)
RU (1) RU2201232C2 (pt)
SK (1) SK284195B6 (pt)
TR (1) TR199800128T1 (pt)
UA (1) UA54397C2 (pt)
WO (1) WO1997006806A1 (pt)
ZA (1) ZA966775B (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6663967B1 (en) * 2000-11-17 2003-12-16 Bryant Rubber Corporation Moldable silicone elastomers having selective primerless adhesion
EP2094273B1 (en) * 2006-11-16 2013-03-06 Gemmus Pharma Inc. EP2 and EP4 agonists as agents for the treatment of influenza A viral infection
EP2803365A1 (en) 2013-05-14 2014-11-19 Commissariat A L'energie Atomique Et Aux Energies Alternatives Use of clonazepam in combination with antibiotic in the treatment of bacterially induced meningitis
WO2021163400A1 (en) 2020-02-12 2021-08-19 Cytoagents, Inc. Compositions and methods for treating coronavirus infections

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US447802A (en) * 1891-03-10 Irvest williams
DE2845770A1 (de) * 1978-10-19 1980-04-30 Schering Ag Neue prostacyclin-derivate und verfahren zu ihrer herstellung
JPS58124778A (ja) * 1982-01-20 1983-07-25 Toray Ind Inc ５，６，７−トリノル−４，８−インタ−ｍ−フエニレンＰＧＩ↓２誘導体
US4665088A (en) * 1984-11-14 1987-05-12 The Research Foundation Of State University Of New York (E-Z)-4,5,9-trithiadodeca-1,6,11-triene 9-oxides
ZA871143B (en) * 1986-02-18 1988-09-28 Syntex Inc Anti-infective injectable formulations
DE4104607A1 (de) * 1991-02-12 1992-08-13 Schering Ag Prostacyclin- und carbacyclinderivate als mittel zur behandlung von fiebrigen erkrankungen
DK0758233T3 (da) * 1994-04-21 2004-03-22 Schering Ag PDE IV-inhibitorer til behandling af multipel sklerose

Also Published As

Publication number Publication date
SK15698A3 (en) 1998-06-03
EP0852497A1 (en) 1998-07-15
DE69621939T2 (de) 2003-01-09
WO1997006806A1 (en) 1997-02-27
CZ41498A3 (cs) 1998-09-16
US6040336A (en) 2000-03-21
DK0852497T3 (da) 2002-08-12
CN1192684A (zh) 1998-09-09
IL122826A0 (en) 1998-08-16
TR199800128T1 (xx) 1998-04-21
NO316424B1 (no) 2004-01-26
SK284195B6 (sk) 2004-10-05
DE19530884A1 (de) 1997-02-20
NO980568D0 (no) 1998-02-10
JPH11510809A (ja) 1999-09-21
RU2201232C2 (ru) 2003-03-27
ES2181907T3 (es) 2003-03-01
MX9801118A (es) 1998-10-31
PL324884A1 (en) 1998-06-22
PL184840B1 (pl) 2002-12-31
CA2228036A1 (en) 1997-02-27
CN1080562C (zh) 2002-03-13
NO980568L (no) 1998-02-10
EP0852497B1 (en) 2002-06-19
ZA966775B (en) 1997-02-19
HUP9802450A2 (hu) 1999-02-01
ATE219368T1 (de) 2002-07-15
DE69621939D1 (de) 2002-07-25
CZ291534B6 (cs) 2003-03-12
DE19530884C2 (de) 1997-07-31
BR9609932A (pt) 1999-06-08
IL122826A (en) 2001-11-25
HK1015707A1 (en) 1999-10-22
AU6871196A (en) 1997-03-12
UA54397C2 (uk) 2003-03-17
AU702706B2 (en) 1999-03-04
HUP9802450A3 (en) 1999-08-30

Similar Documents

Publication Publication Date Title
ES2131496T3 (es) Mejoras relativas a derivados glicopeptidicos.
PT688789E (pt) Processo de lipopeptideos processo para a sua preparacao e sua utilizacao
AP9801283A0 (en) Carbamoyloxy derivatives of mutiline and their use as antibacterials.
NZ504503A (en) Oxazolidinone derivatives and pharmaceutical use as antimicrobial agents
ATE161265T1 (de) Derivate von 16-gliedrigen antibiotischen macroliden
RU94030236A (ru) Производные 3 бета-алкенил-пенама, способ их получения, лекарственные средства и их применение для борьбы и предупреждения болезней
PL358666A1 (en) 2-hydroxy-mutilin carbamate derivatives for antibacterial use
AR005642A1 (es) Compuestos antibioticos de cefalosporina, uso de los mismos para preparar composiciones farmaceuticas, dichas composiciones farmaceuticas que los comprenden,compuestos intermediarios de aplicacion en la preparacion de los primeros y metodo para elaborar dichos compuestos intermediarios
FI962488A0 (fi) HIV:n proteaasin inhibiittoreita
MX9708452A (es) Inhibidores de sialidasa bacteriana y metodos para fabricar y usar la misma.
ATE258057T1 (de) Therapeutische und diagnostische agenzien zur behandlung mikrobieller infektionen
DK312688A (da) Glykkopeptid-antibiotika
ATE205505T1 (de) Basische oxazolinamid-derivate von ge2270 und ge2270-änlichen antibiotika
DK0801655T3 (da) Basiske prolinamidderivater af GE 2270 og GE 2270-lignende antibiotika
PT852497E (pt) Utilizacao de derivados de prostano e a sua combinacao com antibioticos no tratamento de infeccoes bacterianas
DE60030300D1 (de) Topische behandlung zur vorbeugung von augeninfektionen
BG101996A (en) 9-n-ethylenederivatives of 9(s)-erythromycylamine
NO890287L (no) Fremstilling av beta-laktam-antibiotika.
AP9701040A0 (en) Novel compounds.